{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:23:47Z","timestamp":1774355027836,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,4]]},"DOI":"10.7759\/cureus.16880","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T15:51:53Z","timestamp":1628092313000},"source":"Crossref","is-referenced-by-count":4,"title":["A Rare Presentation of a Rare Disease: Oropharyngeal Dysphagia as The Main Manifestation of Myasthenia Gravis"],"prefix":"10.7759","author":[{"given":"Mohammad","family":"Abudalou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Malkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel R","family":"Robles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo A","family":"Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C. C","family":"Slama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.otc.2013.08.008","article-title":"Causes of dysphagia among different age groups: a systematic review of the literature","volume":"46","author":"Roden DF","year":"2013","unstructured":"Roden DF, Altman KW. Causes of dysphagia among different age groups: a systematic review of the literature. Otolaryngol Clin North Am. 2013, 46:965-87. 10.1016\/j.otc.2013.08.008","journal-title":"Otolaryngol Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S23404","article-title":"Dysphagia in the elderly: management and nutritional considerations","volume":"7","author":"Sura L","year":"2012","unstructured":"Sura L, Madhavan A, Carnaby G, Crary MA. Dysphagia in the elderly: management and nutritional considerations. Clin Interv Aging. 2012, 7:287-98. 10.2147\/CIA.S23404","journal-title":"Clin Interv Aging"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4321\/s1130-01082004000200005","article-title":"Approaching oropharyngeal dysphagia. [Article in Spanish]","volume":"96","author":"Clav\u00e9 P","year":"2004","unstructured":"Clav\u00e9 P, Terr\u00e9 R, de Kraa M, Serra M. Approaching oropharyngeal dysphagia. [Article in Spanish]. Rev Esp Enferm Dig. 2004, 96:119-31. 10.4321\/s1130-01082004000200005","journal-title":"Rev Esp Enferm Dig"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus NE","year":"2016","unstructured":"Gilhus NE. Myasthenia gravis. N Engl J Med. 2016, 375:2570-81. 10.1056\/NEJMra1602678","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in myasthenia gravis","volume":"10","author":"Carr AS","year":"2010","unstructured":"Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol. 2010, 10:46. 10.1186\/1471-2377-10-46","journal-title":"BMC Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.03.001","article-title":"Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4","volume":"12","author":"Verschuuren JJ","year":"2013","unstructured":"Verschuuren JJ, Huijbers MG, Plomp JJ, et al.. Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4. Autoimmun Rev. 2013, 12:918-23. 10.1016\/j.autrev.2013.03.001","journal-title":"Autoimmun Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1055\/S-0035-1558975","article-title":"Myasthenia gravis","volume":"35","author":"Gwathmey KG","year":"2015","unstructured":"Gwathmey KG, Burns TM. Myasthenia gravis. Semin Neurol. 2015, 35:327-39. 10.1055\/S-0035-1558975","journal-title":"Semin Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1055\/S-0036-1586265","article-title":"Myasthenia gravis","volume":"36","author":"Drachman DB","year":"2016","unstructured":"Drachman DB. Myasthenia gravis. Semin Neurol. 2016, 36:419-24. 10.1055\/S-0036-1586265","journal-title":"Semin Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"Grob D","year":"2008","unstructured":"Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve. 2008, 37:141-9. 10.1002\/mus.20950","journal-title":"Muscle Nerve"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/21548331.1997.11443447","article-title":"A systematic approach to the patient with dysphagia","volume":"32","author":"Rothstein RD","year":"1997","unstructured":"Rothstein RD. A systematic approach to the patient with dysphagia. Hosp Pract. 1997, 32:169-75. 10.1080\/21548331.1997.11443447","journal-title":"Hosp Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.65.6.848","article-title":"Clinical and electrophysiological evaluation of dysphagia in myasthenia gravis","volume":"65","author":"Ertekin C","year":"1998","unstructured":"Ertekin C, Y\u00fcceyar N, Aydogdu I. Clinical and electrophysiological evaluation of dysphagia in myasthenia gravis. J Neurol Neurosurg Psychiatry. 1998, 65:848-56. 10.1136\/jnnp.65.6.848","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-86432-2_196","article-title":"Esophageal manometric studies in patients with myasthenia gravis","author":"Huang MH","year":"1988","unstructured":"Huang MH, King KL, Hsu HK, Chien KY. Esophageal manometric studies in patients with myasthenia gravis. Diseases of the Esophagus. Siewert JR, H\u00f6lscher AH (ed): Springer, Berlin\/Heidelberg; 1988. 893-6. 10.1007\/978-3-642-86432-2_196"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.01.010","article-title":"Diagnosis of myasthenia gravis","volume":"36","author":"Pasnoor M","year":"2018","unstructured":"Pasnoor M, Dimachkie MM, Farmakidis C, Barohn RJ. Diagnosis of myasthenia gravis. Neurol Clin. 2018, 36:261-74. 10.1016\/j.ncl.2018.01.010","journal-title":"Neurol Clin"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821e5505","article-title":"Comparison of IVIg and PLEX in patients with myasthenia gravis","volume":"76","author":"Barth D","year":"2011","unstructured":"Barth D, Nouri MN, Ng E, Nwe P, Bril V. Comparison of IVIg and PLEX in patients with myasthenia gravis. Neurology. 2011, 76:2017-23. 10.1212\/WNL.0b013e31821e5505","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard JF Jr","year":"2017","unstructured":"Howard JF Jr, Utsugisawa K, Benatar M, et al.. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol. 2017, 16:976-86. 10.1016\/S1474-4422(17)30369-1","journal-title":"Lancet Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/J.AUTREV.2020.102712","article-title":"Update in immunosuppressive therapy of myasthenia gravis","volume":"20","author":"Lascano AM","year":"2021","unstructured":"Lascano AM, Lalive PH. Update in immunosuppressive therapy of myasthenia gravis. Autoimmun Rev. 2021, 20:10.1016\/J.AUTREV.2020.102712","journal-title":"Autoimmun Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/64185-a-rare-presentation-of-a-rare-disease-oropharyngeal-dysphagia-as-the-main-manifestation-of-myasthenia-gravis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:26Z","timestamp":1707507206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/64185-a-rare-presentation-of-a-rare-disease-oropharyngeal-dysphagia-as-the-main-manifestation-of-myasthenia-gravis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,4]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.16880","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,4]]}}}